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Abstract: Prediction of intraoperative difficulties may be helpful in planning surgery; however, few
studies explored this issue in laparoscopic splenectomy (LS). We performed retrospective analysis
of consecutive 468 patients undergoing LS from 1998 to 2017 (295 women; median age 47 years).
The patients were divided into difficult LS and control groups. The inclusion criteria for difficult
LS were operative time ≥mean + 2SD; intraoperative blood loss ≥500 mL, intraoperative adverse
events (IAE), conversion. Primary outcomes were risk factors for difficult splenectomy and secondary
outcomes for perioperative morbidity. Fifty-six patients were included in the difficult LS group (12%).
Spleens ≥19 cm and higher participation of younger surgeons in consecutive years were predictive for
difficult splenectomy. Age ≥53 years and diagnosis other than idiopathic thrombocytopenic purpura
(ITP) were independent risk factors of spleen ≥19 cm. The perioperative morbidity was 8.33%; its OR
was increased only by blood loss and IAEs. Only blood loss significantly increased serious morbidity.
Male sex, spleens ≥19 cm, and IAEs were independent risk factors for intraoperative hemorrhage.
Spleen length ≥19 cm was a risk factor for difficult LS and intraoperative hemorrhage. Diagnoses
other than ITP in patients aged ≥53 years with ≥19 cm spleens are predictive for intraoperative
difficulties and perioperative complications.
Keywords: laparoscopic splenectomy; intraoperative difficulties; hemorrhage; perioperative
complications; surgical education
1. Introduction
Despite controversies regarding who first performed laparoscopic splenectomy (LS) and when,
this procedure relatively quickly became very popular. For more than 25 years, LS replaced traditional
open splenectomy in most centers [1], and many LS procedures were performed. Numerous studies
were followed to explore the identification of patients who may benefit from minimally invasive
approaches, and those who would benefit better from the traditional procedure. Norman Halpern
observed that “to understand how best to deal with the various aspects of laparoscopic difficulties, it is
wise to review what takes place during the uneventful laparoscopy” [2]. Good examples of profound
analyses of the risk factors for difficulty, intraoperative adverse events (IAEs), or conversions to the
open approach include the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
Safe Cholecystectomy Program, and the Tokyo Guidelines. The aim was to avoid serious postoperative
complications, mainly bile tree injuries. Many risk factors for difficult cholecystectomy were identified,
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including age, male sex, episodes of acute cholecystitis, obesity, previous abdominal surgery, clinical
signs of acute cholecystitis, and certain ultrasonographic findings [3]. Despite our best efforts, we were
not able to find studies documenting a similar attempt for LS. This was the inspiration for the current
present study. Our objective was to identify predictive factors for difficult LS.
Considering the safety of the procedure, its risk factors for intraoperative difficulties and
adverse events must be studied [4]. Based on our 20 years of collective experience and more than
500 laparoscopic operations of the spleen, we believe that the thorough analysis of materials focused
on this issue can help to identify important solutions to this problem [5]. The level of difficulty during
surgery can be measured by operation time, blood loss, and conversion rate [6]. The definition of
difficult operation is based on subjective criteria; however, all surgeons and residents performing
this procedure in our high-volume referral center pointed to prolonged operative time, incidence
of IAEs, greater than usual blood loss, and need for conversion as important aspects of a difficult
procedure. We hypothesized that this situation is more common in male patients, in obese patients, in
cases of larger spleen (a usual finding among patients operated for other indications than idiopathic
thrombocytopenic purpura (ITP)), in patients with hemorrhagic diathesis, and when LS is performed by
younger surgeons. The next important issue is to identify how difficult LS influences the postoperative
outcome. Addressing the issue of difficult LS may inspire the establishment of guidelines for safe LS
as in the case of laparoscopic cholecystectomy.
The aim of the study was to find possible risk factors associated with difficult LS and analyze its
influence on postoperative morbidity.
2. Material and Methods
2.1. Design
We designed a case–control study based on the retrospective analysis of consecutive patients
undergoing laparoscopic total splenectomy at a university hospital (tertiary referral surgical center)
from September 1998 to December 2017. The data were collected in a prospective database adhering to
the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force report [7]
by all surgeons. All patients were strictly followed up through 30 postoperative days. We included the
preoperative and perioperative demographic and clinical data for all cases. The study complies with
the STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) guidelines [8].
Inclusion criteria in study population: elective, total laparoscopic splenectomy.
Inclusion criteria for the ‘difficult splenectomy’ group were: operative time ≥mean + 2 standard
deviations (SD), intraoperative blood loss ≥500 mL, occurrence of IAE, and need for conversion to
open approach.
Exclusion criteria were patients with splenic trauma, initially submitted to open surgery, partial
resections and other spleen-preserving procedures, patients in whom hand-assisted LS (HALS) and
single-incision LS techniques were used, or incomplete data.
The patients were divided into two groups: patients who underwent operations regarded as
difficult were in the difficult LS group and other patients were in the control group.
2.2. Outcomes
The primary outcomes are risk factors for difficult LS, while the secondary outcome is determining
the relationship between difficult LS and perioperative morbidity, among other risk factors.
2.3. Definitions
The length of the spleen is defined as the longest diameter of this organ measured during the
abdominal ultrasonography (US) performed by a surgeon just before surgery. The measurement of
operative time started from skin incision and ended with closure. The intraoperative blood loss was
the amount of blood aspirated in the suction machine. IAEs were defined as any iatrogenic harmful
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event occurring during the operation, which had not derived from standard course of operation.
Intraoperative blood loss ≥500 mL was considered to be a hemorrhage because losing less than
one unit of blood (≈500 mL) usually does not negatively condition of patient and does not lead to
hypovolemia and hemorrhagic shock [9,10]. Indications for transfusion were hemorrhagic shock,
hemoglobin ≤6 g % or 6–8 g % in the case of evidence for limited compensation and risk factors
(e.g., coronary heart disease, systolic heart failure, insufficient cerebral vascular flow) or presence of the
following symptoms: tachycardia, hypotension, acute coronary ischemia in electrocardiography (ECG),
and acidosis [11]. Perioperative morbidity was defined as any complication or deviation from routine
postoperative course observed during 30 days after LS (graded with Clavien–Dindo classification [12]).
2.4. Operative Technique
Primary choice of the operative access to peritoneal cavity during LS was a laparoscopic
4 port technique. LS was standardized, similarly with technical considerations described by
Misiakos et al. [13]. After transection of gastrosplenic ligament and short gastric vessels with various
energy devices, extensive lateral mobilization of the spleen was performed. There were two different
techniques of control of splenic vessels. At the beginning of our experience we used, in all cases,
a technique referred to as ‘vessels first’, described elsewhere [14,15]. In this technique, the main trunks
of splenic artery and vein were identified at the level of pancreatic body/tail, isolated, clipped, and
transected. Then, the entire splenic hilum, including branches of all vessels, perivascular fat, and
lymphatic tissue, were dissected away in one block from the pancreatic tail, and removed together
with the spleen. Later, a different technique referred to as ‘hilar transection’ was introduced, where
main, nominate splenic vessels were not isolated. The entire splenic hilum was transected, as close as
possible to splenic parenchyma with the new generation of energy devices—Ligasure® (Covidien) and,
later, Thunderbeat® (Olympus). Occasionally, some clips are put on larger branches of vessels in the
hilum, and the decision about its use belongs to the operating surgeon.
2.5. Ethics
This study was conducted according to the Report of the ISPOR Task Force on Retrospective
Databases [7]. All procedures followed the ethical standards of the responsible committees on human
experimentation (institutional and national) and the 2013 Fortaleza revision of the 1975 Declaration
of Helsinki. The study was approved by an independent ethics committee at Jagiellonian University,
Krakow, Poland (approval number: 1072/6120/160/2017). Informed consent for the surgical treatment
was obtained from all patients before the procedure.
2.6. Statistical Analysis
All data were analyzed with Statistica software (version 13.0; StatSoft, Tulsa, OK, USA). The results
are presented as mean ± SD, median, and interquartile range (IQR), when appropriate. The study of
categorical variables used the Pearson’s chi-square test and chi-square with Yates’ correction when
appropriate. The Shapiro–Wilk test was used to check for normal distribution of data. Quantitative data
were analyzed with Student’s t-test (for normally distributed data) and the Mann–Whitney U-test (for
nonnormally distributed data). Finally, univariate and multivariate logistic regression analyses were
built to identify risk factors for primary and secondary outcomes. Receiver operating characteristic
(ROC) curves were used for setting cut-off points. The results were considered statistically significant
when their p-value was found to be less than 0.05.
2.7. Material
In total, 468 LS were included in the study. The study group consisted of 295 (63%) women and
173 (37%) men. Their median age was 47 years (15–84 years). Their median preoperative body mass index
was 25.89 (22.94–29.32). The indications for splenectomy are presented in Table 1. The most common
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indication for LS was ITP (253 cases, 54.06%). Lymphoma was the second most common indication
(101 cases, 21.58%). The median length of the spleen, according to US, was 14 cm (11–17 cm) (Table 1).
Table 1. Indications for LS.
Indication Number (%) Median US Size of the Spleen, cm (IQR)
ITP 253 (53.26%) 11 (10–13)
Lymphoma 101 (21.58%) 19 (17–23)
Spherocytosis 28 (5.98%) 18 (15–20)
Autoimmune anemia 21 (4.49%) 15 (14–17)
Tumor 20 (4.27%) 14 (11–15.5)
Splenomegaly 22 (4.70%) 18 (16–20)
Leukemia 8 (1.71%) 17.5 (16–21)
Other 15 (3.21%) 15 (12–20)
Total 468 (100%) 14 (11–17)
LS—laparoscopic splenectomy, ITP—idiopathic thrombocytopenia, US—ultrasonography, IQR—interquartile range.
3. Results
The median operative time in the entire group was 100 min (70–130 min). The median blood loss
was 50 mL (20–120 mL). IAEs occurred in 38 patients (8.12%), and are presented in detail in Table 2,
along with the reasons for conversion to open techniques. Conversion was necessary in 14 cases
(2.99%). The conversion rate for LS of spleens ≥19 cm was 6.32%, while the conversion rate for LS
of spleens <19 cm was 1.28% (p = 0.003). Based on our criteria for ‘difficult splenectomy’—operative
time ≥mean + 2SD or intraoperative blood loss ≥500 mL or intraoperative adverse events or need
for conversion to open approach—56 patients were included in the ‘difficult splenectomy’ group
(12%), while 412 (88%) in control group. Using univariate logistic regression model, we sought for risk
factors for ‘difficult splenectomy’ (Table 3). Based on our criteria for difficult LS, i.e., operative time
≥mean + 2SD, intraoperative blood loss ≥500 mL, IAEs, or need for conversion to open approach,
56 patients were included in the difficult LS group (12%) while 412 patients (88%) were included in the
control group. Using a univariate logistic regression model, we identified risk factors for difficult LS
(Table 3). Based on the multivariate logistic regression model, the preoperative length of spleen and
year of surgery were found to be predictive for difficult LS. Other factors were significant in univariate
models, but were shown to be nonsignificant in the multivariate approach. Using ROC curve analysis,
we determined the cut-off point for length of spleen as measured by US that is predictive for difficult
LS as 19 cm (area under the curve = 0.742; 95% confidence interval (CI): 0.672–0.812; p <0.001). We also
analyzed preoperative determinants that can be predictive about spleen ≥19 cm in length as the
only significant factor strongly increasing the risk for difficult LS (Table 4). Age ≥53 years (odds
ratio (OR) = 2.43; 95% CI: 1.39–4.24) and diagnosis other than ITP (OR = 33.59; 95% CI: 11.92–94.67)
were identified as independent prognostic factors of spleen ≥19 cm in length, and indirect for having
difficult LS.
Table 2. Intraoperative adverse events and reasons for conversions.
Intraoperative Adverse Events Number of Cases
Accidental injury of
intraabdominal organ
Stomach 2 (0.43%)
Splenic flexure 2 (0.43%)
Diaphragm (sutured without chest tube) 1 (0.21%)
Small bowel 1 (0.21%)
Pancreatic tail 1 (0.21%)
Bladder (Pfannenstiel incision) 1 (0.21%)
Massive bleeding Managed laparoscopically 20 (4.27%)
Requiring conversion 5 (1.07%)
Rupture of the retrieval bag 5 (1.07%)
Total 38 (8.12%)
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Table 2. Cont.
Reasons for Conversions Number of Cases
Bleeding 5 (1.07%)
Technical problems 4 (0.85%)
Infiltration of surrounding structures 3 (0.64%)
Spleen’s friability 1 (0.21%)
Size of the spleen 1 (0.21%)
Total 14 (2.99%)
Table 3. Risk factors for difficult splenectomy.
Parameter DifficultSplenectomy Control Group OR 95% CI p-Value
n (%) 56 (12%) 412 (88%) n/a n/a n/a
Univariate
Age, median years (IQR) 51 (35–62) 46 (28–58) 1.01 1.00–1.03 0.150
Males/Females, n (%) 29/27 (52%/48%) 144/268 (35%/65%) 0.50 0.28–0.88 0.016
BMI, median kg/m2 (IQR) 26.43 (23.66–28.04) 25.83 (22.55–29.38) 0.99 0.91–1.08 0.790
ITP vs. other, n (%) 18/38 (32%/68%) 235/177 (57%/43%) 2.80 1.54–5.08 0.001
US length of spleen, median cm (IQR) 19 (14–22) 13 (11–17) 1.14 1.09–1.20 <0.001
US length of spleen ≥19 cm, n (%) 28 (54%) 60 (15%) 6.59 3.57–12.16 <0.001
Lowest preoperative platelets, median
103/mm3 (IQR) 8 (6–23) 8 (3–15) 1.00 0.98–1.03 0.772
Preoperative platelets, median
103/mm3 (IQR) 55 (31–64) 83 (50–120) 1.00 0.99–1.03 0.268
Need for extra method of preparing
patients for LS, n (%) 20 (36%) 252 (61%) 0.35 0.20–0.63 <0.001
Accessory spleen, n (%) 4 (7.14%) 69 (16.75%) 0.38 0.12–1.10 0.073
Technique, n (%)
-vessels first 19 (34%) 150 (36%) 1.15 0.58–2.25 0.694
-hilar transection 37 (66%) 262 (64%)
Year of surgery 1.07 1.01–3.90 0.027
Multivariate
Male sex 0.58 0.31–1.10 0.094
Diagnosis other than ITP 0.98 0.35–2.75 0.965
US length of spleen ≥19 cm 5.46 2.45–12.18 <0.001
Need for extra method of preparing
patients for LS 0.87 0.33–2.27 0.768
Year of surgery 1.10 1.10–1.19 0.011
IQR—interquartile range, OR—odds ratio, CI—confidence interval, BMI—body mass index, ITP—idiopathic
trombocytopenia, US—ultrasound, LS—laparoscopic splenectomy.
Table 4. Risk factors for spleen ≥19 cm in length.
Parameter ≥19 cm <19 cm OR 95% CI p-Value
n (%) 91 (19%) 377 (81%) n/a n/a n/a
Univariate
Age, median years (IQR) 59 (44–67) 44 (27–56) 1.04 1.03–1.06 <0.001
Age ≥53 years, n (%) 60 (66%) 125 (33%) 3.92 2.39–6.41 <0.001
Males/Females, n (%) 44/47 (48%/52%) 131/246 (35%/65%) 1.80 1.12–2.88 0.015
BMI, median kg/m2 (IQR) 25.52 (23.29–28.04) 26.02 (22.48–29.38) 0.99 0.92–1.07 0.891
Obesity, n (%) 11 (12%) 74 (20%) 0.58 0.21–1.63 0.300
ITP vs. other, n (%) 4/87 (4%/96%) 247/130 (66%/34%) 39.98 14.28–111.92 <0.001
Year of surgery 1.06 0.99–1.12 0.052
Multivariate
Age ≥53 years 2.43 1.39–4.24 0.002
Females 0.60 0.34–1.04 0.066
Diagnosis other than ITP 33.59 11.92–94.67 <0.001
IQR—interquartile range, OR—odds ratio, CI—confidence interval, BMI—body mass index, ITP—
idiopathic trombocytopenia.
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We noted perioperative morbidity of 8.33% (39 cases). Perioperative complications are listed
in Table 5.
Table 5. Perioperative (≤30 days) complications according to Clavien–Dindo grading.
C–D Complications Number of Cases
5
Pulmonary embolism (patient death) 1 (0.21%)
Massive intraoperative blood loss. Reoperation for recurrent hemorrhage (patient death) 1 (0.21%)
4b Pancreatic fistula with abscess and secondary perforation of splenic flexure. Multiplereoperations. Cardiorespiratory failure (ICU stay) 1 (0.21%)
3b
Postoperative bleeding (relaparoscopy) 6 (1.28%)
Subphrenic abscess (reoperation) 6 (1.28%)
Acute pancreatitis (reoperation) 2 (0.43%)
Perforation of the fundus of the stomach probably due to thermal injury (reoperation on
8th postoperative day) 1 (0.21%)
Thrombosis of superior mesenteric artery (revascularization) 1 (0.21%)
3a
Subphrenic abscess (percutaneous drainage) 1 (0.21%)
Port-site bleeding (suture-ligation under local anesthesia) 1 (0.21%)
Pelvic hematoma (percutaneous drainage) 1 (0.21%)
Pneumothorax (chest tube) 1 (0.21%)
2
Fever of unknown origin 7 (1.50%)
Pulmonary infection 2 (0.43%)
Urinary tract infection 1 (0.21%)
Superior mesenteric vein thrombosis 1 (0.21%)
Subphrenic hematoma 1 (0.21%)
1
Subphrenic fluid collection 3 (0.64%)
Pneumothorax (spontaneous resolution) 1 (0.21%)
Total 39 (8.33%)
C–D—Clavien–Dindo, ICU—Intensive Care Unit.
Difficult splenectomy was not related to increase in odds of perioperative morbidity (OR = 1.69;
95% CI: 0.71–4.06). In all tested risk factors, only blood loss and IAEs were shown to significantly
increase the odds for perioperative morbidity, but only in univariate logistic regression models.
The multivariate logistic regression model revealed that those factors were not independent risk factors
for 30-day complications, as presented in Table 6.
Table 6. Risk factors for perioperative morbidity.
Parameter Complicated Non-Complicated OR 95% CI p-Value
Difficult splenectomy, n (%) 7 (12.50%) 49 (87.50%)
1.69 0.71–4.06 0.234No difficult splenectomy, n (%) 32 (7.77%) 380 (92.23%)
Age, median years (IQR) 40 (27–57) 47 (29–59) 0.99 0.97–1.01 0.162
Males/Females, n (%) 17/22 (44%/56%) 156/273 (36%/64%) 0.74 0.38–1.44 0.372
BMI, median kg/m2 (IQR) 27.51 (23.36–32.37) 25.82 (22.94–29.28) 1.06 0.92–1.22 0.442
ITP vs. other, n (%) 22/17 (56%) 231/198 (54%) 0.90 0.46–1.75 0.758
US length of spleen, median cm (IQR) 14.5 (12–18) 13.5 (11–17) 1.02 0.96–1.08 0.548
Lowest preoperative platelets, median
103/mm3 (IQR) 10 (2.5–21.5) 8 (4–15) 1.00 0.97–1.03 0.963
Preoperative platelets, median
103/mm3 (IQR) 69 (38–126) 79.5 (50–120) 1.00 0.99–1.01 0.695
Need for extra method of preparing
patients for LS, n (%) 23 (58.97%) 249 (58.04%) 1.04 0.52–2.06 0.912
Accessory spleen, n (%) 7 (17.95%) 66 (15.38%) 1.20 0.51–2.85 0.673
Technique, n (%)
-vessels first 17 (44.74%) 147 (35.34%) 0.68 0.234–1.32 0.251
-hilar transection 21 (55.26%) 269 (64.66%)
Operative time, median min (IQR) 95 (75–120) 100 (70–130) 0.99 0.98–1.01 0.614
Blood loss, median ml (IQR) 100 (40–175) 50 (20–100) 1.01 1.00–1.02 0.003
Conversion, n (%) 1 (2.56%) 13 (3.03%) 0.84 0.11–6.64 0.870
Intraoperative adverse events, n (%) 5 (12.82%) 20 (4.66%) 3.01 1.06–8.54 0.038
Year of surgery 0.93 0.87–1.01 0.050
Multivariate
Blood loss ≥500 mL 2.94 0.70–12.27 0.138
Intraoperative adverse events 1.00 0.99–1.02 0.210
IQR—interquartile range, OR—odds ratio, CI—confidence interval, BMI—body mass index, ITP—
idiopathic trombocytopenia.
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We noted 23 cases (4.91%) of serious complications (III–V classes according to Clavien–Dindo
classifications). We tested all possible patient- and treatment-related risk factors for serious
perioperative morbidity; however, only intraoperative blood loss was shown to significantly increase
the ORs for morbidity (OR = 1.01; 95% CI: 1.00–1.02; p = 0.029). (Table 7).
Table 7. Risk factors for perioperative serious perioperative morbidity (Clavien–Dindo III–V).
Parameter Complicated Non-Complicated OR 95% CI p-Value
Difficult splenectomy, n (%) 5 (8.93%) 51 (91.07%)
0.01 0.003–1.62 0.996No difficult splenectomy, n (%) 18 (4.37%) 394 (95.63%)
Age, median (IQR) 47 (29–60) 47 (29–59) 0.99 0.97–1.02 0.964
Males/Females, n (%) 12/11 (52%/48%) 161/284 (36%/64%) 0.52 0.22–1.21 0.127
BMI, median kg/m2 (IQR) 27.51 (18.59–32.37) 25.83 (22.94–29.32) 1.01 0.86–1.19 0.913
ITP vs. other, n (%) 13/10 (57%/43%) 240/205 (54%/46%) 0.90 0.39–2.10 0.808
US length of spleen, median cm (IQR) 14.5 (12–17) 14 (11–17) 1.03 0.95–1.11 0.454
Lowest preoperative platelets, median
103/mm3 (IQR) 7 (1–12) 8 (4–17) 0.98 0.93–1.03 0.452
Preoperative platelets, median
103/mm3 (IQR) 59 (31–102) 79.5 (50–120) 0.99 0.98–1.00 0.246
Need for extra method of preparing
patients for LS, n (%) 15 (65%) 257 (58%) 1.37 0.57–3.31 0.481
Accessory spleen, n (%) 5 (21.74%) 68 (15.28%) 1.54 0.55–4.30 0.408
Technique, n (%)
-vessels first 7 (30.43%) 157 (36.43%) 1.31 0.53–3.26 0.561
-hilar transection 16 (69.57%) 274 (63.57%)
Operative time, median min (IQR) 105 (80–120) 100 (70–130) 0.99 0.99–1.01 0.945
Blood loss, median ml (IQR) 100 (30–200) 50 (20–100) 1.01 1.00–1.02 0.029
Conversion, n (%) 0 14 (3.15%) n/a n/a n/a
Intraoperative adverse events, n (%) 3 (13.04%) 22 (4.94%) 2.88 0.79–10.48 0.107
Year of surgery 0.97 0.89–1.06 0.475
IQR—interquartile range, OR—odds ratio, CI—confidence interval, BMI—body mass index, ITP—idiopathic
trombocytopenia, US—ultrasound.
Therefore, intraoperative blood loss was both a risk factor for general perioperative morbidity,
as well as for serious perioperative complications; thus, what were the risk factors for significant
intraoperative blood loss (≥500 mL)? The multivariate logistic regression analysis showed that
male sex (OR = 2.97; 95% CI: 1.01–8.68), length of spleen ≥19 cm measured by US (OR = 10.96;
95% CI: 2.24–53.52), and IAEs other than hemorrhage (OR = 22.27; 95% CI: 6.20–80.0), were independent
risk factors for intraoperative bleeding (Table 8).
Table 8. Risk factors for intraoperative blood loss ≥500 mL.
Parameter ≥500mL Control OR 95% CI p-Value
n (%) 25 (5.34%) 443 (94.66%) n/a n/a n/a
Univariate
Age, median (IQR) 54 (40–63) 50 (32–53) 1.01 0.99–1.04 0.373
Males/Females, n (%) 15/10 (60%/40%) 156/287 (35%/65%) 2.75 1.19–6.38 0.018
BMI, median kg/m2 (IQR) 26.66 (23.66–28.04) 25.98 (22.74–29.39) 0.99 0.90–1.10 0.917
Obesity, n (%) 3 (12%) 89 (20%) 0.50 0.11–2.29 0.366
ITP vs. other, n (%) 7/18 (28%/72%) 213/230 (48%/52%) 2.39 1.00–5.93 0.044
US length of spleen, median cm (IQR) 20 (17–25) 14 (11–17) 1.24 1.14–1.34 <0.001
US length of spleen ≥19 cm, n (%) 17 (68%) 71 (16%) 11.12 4.50–27.49 <0.001
Lowest preoperative platelets, median
103/mm3 (IQR) 10 (7–38) 7.5 (3–17) 1.01 0.98–1.04 0.479
Preoperative platelets, median
103/mm3 (IQR) 51 (28–63) 84.5 (50–120) 0.99 0.97–1.00 0.064
Need for extra method of preparing
patients for LS, n (%) 8 (32%) 236 (53%) 0.41 0.17–0.99 0.047
Accessory spleen, n (%) 1 (4%) 67 (15%) 0.23 0.03–1.80 0.161
Technique, n (%)
-vessels first 7 (28%) 56 (13%) 0.41 0.14–1.20 0.102
-hilar transection 18 (72%) 387 (87%)
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Table 8. Cont.
Parameter ≥500mL Control OR 95% CI p-Value
Intraoperative adverse events other
than hemorrhage, n (%) 12 (48%) 13 (3%) 30.46 10.57–87.76 <0.001
Year of surgery 1.10 0.95–1.28 0.186
Multivariate
Male sex 2.97 1.01–8.68 0.046
Diagnosis other than ITP 1.64 0.11–3.45 0.579
US length of spleen ≥19 cm 10.96 2.24–53.52 0.003
Need for extra method of preparing
patients for LS 1.76 0.38–8.27 0.469
Intraoperative adverse events other
than hemorrhage 22.27 6.20–80.0 <0.001
IQR—interquartile range, OR—odds ratio, CI—confidence interval, BMI—body mass index, ITP—idiopathic
trombocytopenia, US—ultrasound, LS—laparoscopic splenectomy.
4. Discussion
We analyzed of one of the largest single-center outcomes of LS in this study. We addressed the
issues of difficult LS to enable surgeons to be better prepared preoperatively before performing the
procedure. The length of spleen ≥19 cm, as measured by US, was an independent risk factor, and
increased the odds for difficult LS. Despite the surgeons’ sweat and tears during the procedures,
difficult LS did not increase perioperative morbidity. We found intraoperative blood loss to be both
an independent risk factor for general perioperative morbidity, as well as for serious perioperative
complications of LS. The multivariate logistic regression analysis for independent risk factors for
intraoperative hemorrhage revealed that male sex tripled the chances for its occurrence, length of
spleen ≥19 cm measured with US increased odds 11 times and, finally, IAEs other than hemorrhage
resulted in a 22.27-times increase in the odds.
Unfortunately, we could not find any studies analyzing difficult LS. In case of LS, portal
hypertension from liver cirrhosis, severe uncorrected coagulopathy, and massive splenomegaly are
considered as contraindications for the laparoscopic approach [16]. Massive splenomegaly (defined
as a maximum spleen diameter exceeding 25 cm, an estimated spleen volume exceeding 1000 mL,
or both) is described by many researchers as a leading cause of conversion to open techniques, or even
as a contraindication to LS because of the limited abdominal working space, with an increased risk
of bleeding and difficulty retrieving the spleen [16–18]. We also found that spleen ≥19 cm in length
is associated significantly with higher difficulty of LS. Indirectly, we proved that age ≥53 years and
diagnosis other than ITP were identified as independent prognostic factors of spleen ≥19 cm in length.
Thus, higher risk of bleeding, rate of IAEs, and conversion could be expected in older patients and
indications other than ITP. However, adequately used HALS can be an alternative to full conversion,
although it is classified by some as laparoscopy [19,20]. Somasundaram suggests that only very large
spleens (larger than 27 cm) and portal hypertension can be regarded as a relative contraindication to
laparoscopy [21]. The European Association for Endoscopic Surgery (EAES) defined splenomegaly as
a long axis exceeding 15 cm, and massive splenomegaly as a long axis exceeding 20 cm. The EAES
recommend HALS or open splenectomy in the case of massive splenomegaly [6]. However, most
studies clearly demonstrate the benefits of LS even in the case of massively enlarged spleens. This was
very well shown when Bai et al. compared LS to open splenectomy [22]. Throughout our entire
experience, we believe that beginning each procedure laparoscopically is beneficial. In the case of
serious obstacles during procedure, HALS was used as alternative to conversion; however, HALS cases
were excluded from our analysis. In case of spleens ≥19 cm, 6.32% out of 95 cases were converted,
while the conversion rate in LS of spleens <19 cm was 1.28%. Thus, based on our experience, we agree
with the statements in the EAES recommendations and more recent publications by Misiakos et al. [13].
Regardless of its intraoperative difficulties, we believe that LS is a safe procedure with a
low risk of complications and incidental mortality. A meta-analysis by Bai et al. showed much
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better results concerning mortality and morbidity for LS when compared to open operation [22].
Two patients died postoperatively in our series. This mortality of 0.4% was rather low compared
with the ranges presented in the literature (0%–4%) [17,22,23]. Considering perioperative morbidity,
which was also low (8.33%), only 23 patients (4.9%) out of 468 suffered from serious (Clavien–Dindo
III–V) complications. This finding does not differ much from the data presented in the literature,
where postoperative morbidity ranges from 0% to 37.5% [17,23]. Surprisingly, in our series, the
difficult LS did not translate directly into perioperative morbidity. Wang et al. determined that high
comorbidity index and large spleen are independent risk factors for serious perioperative comorbidity
in their analysis of 302 LS cases [23]. Nevertheless, all cited works stated that the most common
and worrisome complication of LS is intraabdominal hemorrhage [22,24–26]. We have also shown
that out of all the possible reasons for regarding splenectomy difficult, only intraoperative blood
loss is a direct, independent risk factor for both general and serious perioperative morbidity. In a
multivariate analysis, massive intraoperative bleeding (≥500 mL blood loss) was related to male
patients (OR = 2.97; 95% CI: 1.01–8.68), enlarged spleens (length of spleen ≥19 cm measured with
US, OR = 10.96; 95% CI: 2.24–53.52), and occurrence of IAEs (excluding hemorrhage, OR = 22.27;
95% CI: 6.20–80.0). The combination of those three risk factors is highly, but indirectly, associated with
perioperative complications. Therefore, those patients require careful postoperative observation and
additional attention.
Another interesting factor is that chances for difficult LS slightly increased with the passage of
time. This is because the operations initially carried out by attending surgeons were later performed
by junior surgeons and residents. All of them had prior experience in laparoscopic surgery, but they
were on the learning curve of LS. The decision to allow trainees to perform LS was left to the senior
attending surgeons of our facility.
Nevertheless, further studies are needed to clearly identify the preoperative and intraoperative
risk factors. Future studies of difficult LS would help to create safety guidelines such as those developed
by SAGES for laparoscopic cholecystectomy. We would like to also endorse the vessels first and HALS
techniques to address some of these intraoperative difficulties, such as an enlarged spleen. However,
this discussion is ongoing.
Our study is limited by typical factors for a single-center retrospective analysis. However, this
is one of the largest published groups of patients undergoing LS in a referral center, where many
procedures are performed annually. Therefore, our results cannot be directly transferred to other
hospitals. The study material consists of operations performed by five surgical teams, not a single
surgeon. Another limitation is the fact that we did not include potential postoperative complications
that might have occurred later than 30 days after discharge in this analysis. These complications
could certainly influence the overall complication rate. The number of explanatory variables may
be excessive for evaluating the effect of each variable because the performance of logistic regression
analysis decreases with the increase in variables per outcome.
5. Conclusions
We showed that spleen length ≥19 cm and higher participation of younger surgeons in consecutive
years increased the possibility of difficult LS and intraoperative hemorrhage. However, this did not
seem to translate to perioperative morbidity related to diagnosis other than ITP, age ≥53 years, and
splenomegaly ≥19 cm.
Author Contributions: Conceptualization, M.W., D.R. and A.B.; Methodology, M.W., A.B., M.R.; Formal Analysis,
M.W., A.Z.; Investigation, M.W., D.R., A.Z., M.R., J.K, P.M., M.P., A.B.; Data Curation, M.W., J.K.; Writing—Original
Draft Preparation, M.W., D.R., A.Z.; Writing—Review & Editing, P.M., M.P., A.B.; Supervision, A.B.
Funding: This research received no external funding.
Acknowledgments: We thank Peter Fogarty, MA English 1st Class, from Edanz Group (www.edanzediting.com/ac),
for editing a draft of this manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
J. Clin. Med. 2018, 7, 547 10 of 11
Abbreviations
LS—laparoscopic splenectomy;
IAE—intraoperative adverse events;
ITP—immune trombocytopenic purpura;
SAGES—Society of American Gastrointestinal and Endoscopic Surgeons;
ISPOR—International Society for Pharmacoeconomics and Outcomes Research;
STROBE—Strengthening the Reporting of Observational studies in Epidemiology;
HALS—hand-assisted laparoscopic surgery;
SILS—single incision laparoscopic surgery;
SD—standard deviation;
ECG—electrocardiography;
IQR—interquartile range;
ROC—receiver operating characteristic curve;
BMI—body mass index;
US—ultrasound/ultrasonography;
EAES—European Association for Endoscopic Surgery.
References
1. Dionigi, R.; Boni, L.; Rausei, S.; Rovera, F.; Dionigi, G. History of splenectomy. Int. J. Surg. 2013, 11, 42–43.
[CrossRef]
2. Halpern, N.B. The difficult laparoscopy. Surg. Clin. North Am. 1996, 76, 603–613. [CrossRef]
3. Gupta, G.; Sharma, P.; Gupta, S.; Bhardwaj, A. Pre and per operative prediction of difficult laparoscopic
cholecystectomy using clinical and ultrasonographic parameters. Int. J. Res. Med. Sci. 2015, 3, 3342–3346.
[CrossRef]
4. Luppi, C.R.-O.; Soler, E.M.T.; Ponz, C.B.; Millán, J.P.P.; Rodriguez, V.T.; Segura, J.L.P.; Rodriguez, J.B.;
Folch, M.T. Clinical, anatomical, and pathological grading score to predict technical difficulty in laparoscopic
splenectomy for non-traumatic diseases. World J. Surg. 2017, 41, 439–448. [CrossRef] [PubMed]
5. Radkowiak, D.; Zychowicz, A.; Lasek, A.; Wysocki, M.; Major, P.; Pedziwiatr, M.; Budzynski, P.; Kulawik, J.;
Budzynski, A. 20 years’ experience with laparoscopic splenectomy. Single center outcomes of a cohort study
of 500 cases. Int. J. Surg. 2018. [CrossRef] [PubMed]
6. Habermalz, B.; Sauerland, S.; Decker, G.; Delaitre, B.; Gigot, J.-F.; Leandros, E.; Lechner, K.; Rhodes, M.;
Silecchia, G.; Szold, A.; et al. Laparoscopic splenectomy: The clinical practice guidelines of the European
Association for Endoscopic Surgery (EAES). Surg. Endosc. 2008, 22, 821–848. [CrossRef]
7. Motheral, B.; Brooks, J.; Clark, M.A.; Crown, W.H.; Davey, P.; Hutchins, D.; Martin, B.C.; Stang, P. A checklist
for retrospective database studies—Report of the ISPOR task force on retrospective databases. Value Health
2003, 6, 90–97. [CrossRef]
8. von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gotzsche, P.C.; Vandenbroucke, J.P. The strengthening
the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting
observational studies. Int. J. Surg. 2014. [CrossRef]
9. Gutierrez, G.; Reines, H.D.; Wulf-Gutierrez, M.E. Clinical review: Hemorrhagic shock. Crit. Care 2004, 8,
373–381. [CrossRef]
10. Kathariya, R.; Devanoorkar, A.; Jain, H. Intra-operative hemorrhage: A review of literature. Med. Diagn. Methods
2013, 2, 1–5. [CrossRef]
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14. Budzyński, A.; Bobrzyński, A.; Krzywoń, J.; Biesiada, Z.; Budzyński, P.; Strzałka, M. Technika “vessel first”
w technicznie trudnej splenektomii laparoskopowej. Pol. J. Surg. 2002, 74, 789–796.
15. Budzynski, A.; Bobrzynski, A.; Krzywon, J. Laparoscopic surgery of the spleen. Przegl. Lek. 2001, 58, 158–161.
J. Clin. Med. 2018, 7, 547 11 of 11
16. Corcione, F.; Pirozzi, F.; Aragiusto, G.; Galante, F.; Sciuto, A. Laparoscopic splenectomy: Experience of a
single center in a series of 300 cases. Surg. Endosc. 2012, 26, 2870–2876. [CrossRef] [PubMed]
17. Moris, D.; Dimitriou, N.; Griniatsos, J. Laparoscopic splenectomy for benign hematological disorders in
adults: A systematic review. In Vivo 2017, 31, 291–302. [CrossRef] [PubMed]
18. Patel, A.G.; Parker, J.E.; Wallwork, B.; Kau, K.B.; Donaldson, N.; Rhodes, M.R.; O’Rourke, N.; Nathanson, L.;
Fielding, G. Massive splenomegaly is associated with significant morbidity after laparoscopic splenectomy.
Ann. Surg. 2003, 238, 235–240. [CrossRef]
19. Bargellini, T.; Martellucci, J.; Bruscino, A.; Prosperi, P.; Valeri, A. Laparoscopic splenectomy 15 years after.
Surg. Laparosc. Endosc. Percutan. Tech. 2014, 24, 47–49. [CrossRef]
20. Wu, Z.; Zhou, J.; Cai, Y.Q.; Liu, S.A.; Peng, B. The learning curve for laparoscopic splenectomy for massive
splenomegaly: A single surgeon’s experience. Chin. Med. J. 2013, 126, 2103–2108. [CrossRef] [PubMed]
21. Somasundaram, S.K.; Massey, L.; Gooch, D.; Reed, J.; Menzies, D. Laparoscopic splenectomy is emerging
“gold standard” treatment even for massive spleens. Ann. R. Coll. Surg. Engl. 2015, 97, 345–348. [CrossRef]
22. Bai, Y.-N.; Jiang, H.; Prasoon, P. A meta-analysis of perioperative outcomes of laparoscopic splenectomy for
hematological disorders. World J. Surg. 2012, 36, 2349–2358. [CrossRef] [PubMed]
23. Wang, X.; Li, Y.; Crook, N.; Peng, B.; Niu, T. Laparoscopic splenectomy: A surgeon’s experience of 302
patients with analysis of postoperative complications. Surg. Endosc. 2013, 27, 3564–3571. [CrossRef]
[PubMed]
24. Patel, N.Y.; Chilsen, A.M.; Mathiason, M.A.; Kallies, K.J.; Bottner, W.A. Outcomes and complications after
splenectomy for hematologic disorders. Am. J. Surg. 2012, 204, 1014–1019. [CrossRef] [PubMed]
25. Musallam, K.M.; Khalife, M.; Sfeir, P.M.; Faraj, W.; Safadi, B.; Saad, G.S.A.; Abiad, F.; Hallal, A.; Alwan, M.B.;
Peyvandi, F.; et al. Postoperative outcomes after laparoscopic splenectomy compared with open splenectomy.
Ann. Surg. 2013, 257, 1116–1123. [CrossRef] [PubMed]
26. Chen, J.; Ma, R.; Yang, S.Z.; Lin, S.; He, S.L.; Cai, X.J. Perioperative outcomes of laparoscopic versus open
splenectomy for nontraumatic diseases: A meta-analysis. Chin. Med. J. 2014, 127, 2504–2510. [CrossRef]
[PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
